Intrathecal Pump Market Size, Share & Trends Analysis | Global | 2023-2029 | MedCore

The global market for intrathecal pumps was valued at $310 million in 2022 and is projected to reach $335 million by the end of the forecast period with a CAGR of 1.1%. The market analysis covers the complete range of intrathecal pumps.

MARKET REPORT DATA TYPES INCLUDED

Unit Sales, Average Selling Prices, Market Size & Growth Trends

Procedure Numbers

COVID-19 Impact Analysis

Market Drivers & Limiters

Market Forecasts Until 2029, and Historical Data to 2019

Recent Mergers & Acquisitions

Company Profiles and Product Portfolios

Leading Competitors

GLOBAL INTRATHECAL PUMP MARKET INSIGHTS

A key driver in the global intrathecal pump market is the technological advancements made in intrathecal pumps, leading to improved efficacy, safety, and longer-lasting pumps. The development of programmable delivery systems has been a response to the issue of variability between patients and within individual patients, and this has contributed to market growth.

GLOBAL INTRATHECAL PUMP MARKET SHARE INSIGHTS

Within the global market for intrathecal pump, there are three key market players - Medtronic, Flowonix, and Tricumed. The global intrathecal pump market was dominated by Medtronic in 2022 with its SynchroMed® II, while Flowonix held the second position with its Prometra® product. Tricumed ranked third in the market due to its siromedes device.

MARKET SEGMENTATION SUMMARY

Global Intrathecal Pump Market

RESEARCH SCOPE SUMMARY

Regions: North America (Canada, United States), Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela), Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.), Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine), Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates), Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam), Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)

Base Year: 2022

Forecast: 2023-2029

Historical Data: 2019-2022

Quantitative Coverage: Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.

Qualitative Coverage: COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.

Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.

WHY CHOOSE IDATA?

Experts Only - iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.

Global Coverage - iData's unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.

Attention to Detail - It's our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.

Pricing - When comparing like-with-like, iData's prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.